{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T14:39:41Z","timestamp":1790692781668,"version":"4.1.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2014,2,12]],"date-time":"2014-02-12T00:00:00Z","timestamp":1392163200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1208\/s12249-014-0086-y","type":"journal-article","created":{"date-parts":[[2014,2,10]],"date-time":"2014-02-10T18:45:05Z","timestamp":1392057905000},"page":"620-629","source":"Crossref","is-referenced-by-count":26,"title":["Liposomal Oxymatrine in Hepatic Fibrosis Treatment: Formulation, In Vitro and In Vivo Assessment"],"prefix":"10.1208","volume":"15","author":[{"given":"Shujuan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiechuang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dandan","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiguang","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subin","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,2,12]]},"reference":[{"issue":"Suppl 1","key":"86_CR1","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1016\/S1590-8658(10)60690-1","volume":"43","author":"M Iavarone","year":"2011","unstructured":"Iavarone M, Colombo M. HBV-related HCC, clinical issues and therapy. Dig Liver Dis. 2011;43 Suppl 1:S32\u20139.","journal-title":"Dig Liver Dis"},{"key":"86_CR2","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.bpg.2011.02.009","volume":"25","author":"M Pinzani","year":"2011","unstructured":"Pinzani M, Rosselli M, Zuckermann M. Liver cirrhosis. Best Pract Res Clin Gastroenterol. 2011;25:281\u201390.","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"86_CR3","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1056\/NEJM200102083440610","volume":"344","author":"PAL Bonis","year":"2001","unstructured":"Bonis PAL, Friedman SL, Kaplan MM. Is liver fibrosis reversible? N Engl J Med. 2001;344:452\u20134.","journal-title":"N Engl J Med"},{"key":"86_CR4","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1055\/s-2007-1007105","volume":"19","author":"SL Friedman","year":"1999","unstructured":"Friedman SL. Cytokines and fibrogenesis. Semin Liver Dis. 1999;19:129\u201340.","journal-title":"Semin Liver Dis"},{"key":"86_CR5","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1046\/j.1440-1746.1999.01928.x","volume":"14","author":"D Li","year":"1999","unstructured":"Li D, Friedman SL. Liver fibrogenesis and the role of hepatic stellate cells: new insights and prospects for therapy. J Gastroenterol Hepatol. 1999;14:618\u201333.","journal-title":"J Gastroenterol Hepatol"},{"key":"86_CR6","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.bpg.2011.02.005","volume":"25","author":"UE Lee","year":"2011","unstructured":"Lee UE, Friedman SL. Mechanisms of hepatic fibrogenesis. Best Pract Res Clin Gastroenterol. 2011;25:195\u2013206.","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"86_CR7","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.1478-3231.2010.02369.x","volume":"31","author":"S Coulon","year":"2011","unstructured":"Coulon S, Heindryckx F, Geerts A, Van Steenkiste C, Colle I, Van Vlierberghe H. Angiogenesis in chronic liver disease and its complications. Liver Int. 2011;31:146\u201362.","journal-title":"Liver Int"},{"key":"86_CR8","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/nnano.2007.387","volume":"2","author":"D Peer","year":"2007","unstructured":"Peer D, Karp JM, Hong S, Farokhzad OC, Margalit R, Langer R. Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol. 2007;2:751\u201360.","journal-title":"Nat Nanotechnol"},{"key":"86_CR9","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/j.1742-7843.2008.00287.x","volume":"103","author":"X Chen","year":"2008","unstructured":"Chen X, Sun R, Hu J, Mo Z, Yang Z, Liao D, et al. Attenuation of bleomycin-induced lung fibrosis by oxymatrine is associated with regulation of fibroblast proliferation and collagen production in primary culture. Basic Clin Pharmacol Toxicol. 2008;103:278\u201386.","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"86_CR10","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1016\/j.intimp.2008.08.008","volume":"8","author":"Y Zhang","year":"2008","unstructured":"Zhang Y, Wang S, Li Y, Xiao Z, Hu Z, Zhang J. Sophocarpine and matrine inhibit the production of TNF-alpha and IL-6 in murine macrophages and prevent cachexia-related symptoms induced by colon26 adenocarcinoma in mice. Int Immunopharmacol. 2008;8:1767\u201372.","journal-title":"Int Immunopharmacol"},{"key":"86_CR11","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.jpba.2006.01.029","volume":"41","author":"XL Wu","year":"2006","unstructured":"Wu XL, Hang TJ, Shen JP, Zhang YD. Determination and pharmacokinetic study of oxymatrine and its metabolite matrine in human plasma by liquid chromatography tandem mass spectrometry. J Pharm Biomed Anal. 2006;41:918\u201324.","journal-title":"J Pharm Biomed Anal"},{"key":"86_CR12","doi-asserted-by":"crossref","first-page":"624","DOI":"10.3109\/1061186X.2010.531731","volume":"19","author":"N Daneshpour","year":"2010","unstructured":"Daneshpour N, Griffin M, Collighan R, Perrie Y. Targeted delivery of a novel group of site-directed transglutaminase inhibitors to the liver using liposomes: a new approach for the potential treatment of liver fibrosis. J Drug Target. 2010;19:624\u201331.","journal-title":"J Drug Target"},{"key":"86_CR13","first-page":"2325","volume":"7","author":"T Wang","year":"2012","unstructured":"Wang T, Yin X, Lu Y, Shan W, Xiong S. Formulation, antileukemia mechanism, pharmacokinetics, and biodistribution of a novel liposomal emodin. Int J Nanomedicine. 2012;7:2325\u201337.","journal-title":"Int J Nanomedicine"},{"key":"86_CR14","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S0083-6729(07)76021-1","volume":"76","author":"A Sario Di","year":"2007","unstructured":"Di Sario A, Candelaresi C, Omenetti A, Benedetti A. Vitamin E in chronic liver diseases and liver fibrosis. Vitam Horm. 2007;76:551\u201373.","journal-title":"Vitam Horm"},{"key":"86_CR15","first-page":"1474","volume":"22","author":"SL Liu","year":"1995","unstructured":"Liu SL, Degli Esposti S, Yao T, Diehl AM, Zern MA. Vitamin E therapy of acute CCl4-induced hepatic injury in mice is associated with inhibition of nuclear factor kappa B binding. Hepatology. 1995;22:1474\u201381.","journal-title":"Hepatology"},{"key":"86_CR16","doi-asserted-by":"crossref","first-page":"599","DOI":"10.3109\/10715769709097863","volume":"27","author":"A Herbay von","year":"1997","unstructured":"von Herbay A, Stahl W, Niederau C, Sies H. Vitamin E improves the aminotransferase status of patients suffering from viral hepatitis C: a randomized, double-blind, placebo-controlled study. Free Radic Res. 1997;27:599\u2013605.","journal-title":"Free Radic Res"},{"key":"86_CR17","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1080\/01635588509513858","volume":"7","author":"L Helson","year":"1985","unstructured":"Helson L, Helson C. Effects of vitamin E on fibroblast fibronectin. Nutr Cancer. 1985;7:221\u20137.","journal-title":"Nutr Cancer"},{"key":"86_CR18","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1111\/j.1478-3231.2009.02011.x","volume":"29","author":"G Latella","year":"2009","unstructured":"Latella G, Vetuschi A, Sferra R, Catitti V, D\u2019Angelo A, Zanninelli G, et al. Targeted disruption of Smad3 confers resistance to the development of dimethylnitrosamine-induced hepatic fibrosis in mice. Liver Int. 2009;29:997\u20131009.","journal-title":"Liver Int"},{"key":"86_CR19","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/1479-5876-11-78","volume":"11","author":"GA Nasir","year":"2013","unstructured":"Nasir GA, Mohsin S, Khan M, Shams S, Ali G, Khan SN, et al. Mesenchymal stem cells and Interleukin-6 attenuate liver fibrosis in mice. J Transl Med. 2013;11:78. doi: 10.1186\/1479-5876-11-78 .","journal-title":"J Transl Med"},{"key":"86_CR20","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s11373-006-9079-5","volume":"13","author":"LW Chong","year":"2006","unstructured":"Chong LW, Hsu YC, Chiu YT, Yang KC, Huang YT. Anti-fibrotic effects of thalidomide on hepatic stellate cells and dimethylnitrosamine-intoxicated rats. J Biomed Sci. 2006;13:403\u201318.","journal-title":"J Biomed Sci"},{"key":"86_CR21","first-page":"1400","volume":"41","author":"CY Miao","year":"2006","unstructured":"Miao CY, Deng SH, Chen JF. Studies on preparation of anionic oxymatrine liposomes and its physicochemical properties. Chin Pharm J. 2006;41:1400\u20134.","journal-title":"Chin Pharm J."},{"key":"86_CR22","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1080\/03639040600760556","volume":"32","author":"S Du","year":"2006","unstructured":"Du S, Deng Y. Studies on the encapsulation of oxymatrine into liposomes by ethanol injection and pH gradient method. Drug Dev Ind Pharm. 2006;32:791\u20137.","journal-title":"Drug Dev Ind Pharm."},{"key":"86_CR23","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jconrel.2009.05.036","volume":"139","author":"D Zucker","year":"2009","unstructured":"Zucker D, Marcus D, Barenholz Y, Goldblum A. Liposome drugs\u2019 loading efficiency: a working model based on loading conditions and drug\u2019s physicochemical properties. J Control Release. 2009;139:73\u201380.","journal-title":"J Control Release"},{"key":"86_CR24","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0005-2736(93)90105-9","volume":"1151","author":"G Haran","year":"1993","unstructured":"Haran G, Cohen R, Bar LK, Barenholz Y. Transmembrane ammonium sulfate gradients in liposomes produce efficient and stable entrapment of amphipathic weak bases. Biochim Biophys Acta. 1993;1151:201\u201315.","journal-title":"Biochim Biophys Acta"},{"key":"86_CR25","doi-asserted-by":"crossref","first-page":"5011","DOI":"10.1002\/jps.22210","volume":"99","author":"S Xiong","year":"2010","unstructured":"Xiong S, Li H, Yu B, Wu J, Lee RJ. Triggering liposomal drug release with a lysosomotropic agent. J Pharm Sci. 2010;99:5011\u20138.","journal-title":"J Pharm Sci"},{"key":"86_CR26","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1016\/j.bbamem.2006.05.028","volume":"1758","author":"A Fritze","year":"2006","unstructured":"Fritze A, Hens F, Kimpfler A, Schubert R, Peschka-S\u00fcss R. Remote loading of doxorubicin into liposomes driven by a transmembrane phosphate gradient. Biochim Biophys Acta. 2006;1758:1633\u201340.","journal-title":"Biochim Biophys Acta"},{"key":"86_CR27","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s00795-006-0311-1","volume":"39","author":"T Ueno","year":"2006","unstructured":"Ueno T, Nakamura T, Torimura T, Sata M. Angiogenic cell therapy for hepatic fibrosis. Med Mol Morphol. 2006;39:16\u201321.","journal-title":"Med Mol Morphol."},{"key":"86_CR28","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.fct.2006.11.007","volume":"45","author":"CP Lee","year":"2007","unstructured":"Lee CP, Shih PH, Hsu CL, Yen GC. Hepatoprotection of tea seed oil (Camellia oleifera Abel.) against CCl4-induced oxidative damage in rats. Food Chem Toxicol. 2007;45:888\u201395.","journal-title":"Food Chem Toxicol"},{"key":"86_CR29","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.colsurfb.2011.01.021","volume":"85","author":"AR Shah","year":"2011","unstructured":"Shah AR, Banerjee R. Effect of d-\u03b1-tocopheryl polyethylene glycol 1000 succinate (TPGS) on surfactant monolayers. Colloids Surf B: Biointerfaces. 2011;85:116\u201324.","journal-title":"Colloids Surf B: Biointerfaces"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-014-0086-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1208\/s12249-014-0086-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-014-0086-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,3]],"date-time":"2019-06-03T23:48:26Z","timestamp":1559605706000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1208\/s12249-014-0086-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2,12]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["86"],"URL":"https:\/\/doi.org\/10.1208\/s12249-014-0086-y","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,12]]}}}